You have 9 free searches left this month | for more free features.

oligodendroglioma

Showing 26 - 50 of 387

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Astrocytoma, Ependymoma, Ganglioglioma Trial in Maastricht, Delft, Groningen (ProTRAIT)

Recruiting
  • Astrocytoma
  • +11 more
  • ProTRAIT
  • Maastricht, Limburg, Netherlands
  • +2 more
Apr 12, 2022

CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

Recruiting
  • Central Nervous System Neoplasms
  • +22 more
  • Bethesda, Maryland
    National Institutes of Health
Mar 1, 2022

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Active, not recruiting
  • Recurrent Anaplastic Astrocytoma
  • +6 more
  • Carboxylesterase-expressing Allogeneic Neural Stem Cells
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Glioma, Pilocytic Astrocytoma, Anaplastic Astrocytoma Trial in Saint Louis (MRI-guided laser ablation, Doxorubicin, Etoposide)

Recruiting
  • Glioma
  • +8 more
  • MRI-guided laser ablation
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 22, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

Recruiting
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +12 more
Jan 9, 2023

Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,

Active, not recruiting
  • Adult Anaplastic Astrocytoma
  • +15 more
  • biopsy
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic
Apr 8, 2022

Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

Recruiting
  • Medulloblastoma
  • +7 more
  • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
  • +2 more
  • Buffalo, New York
  • +2 more
Jul 8, 2022

Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,

Completed
  • Anaplastic Oligoastrocytoma
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Mar 11, 2022

Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion Trial in France (PCV chemo, Radiotherapy and PCV chemo)

Recruiting
  • Oligodendroglioma
  • +2 more
  • PCV chemotherapy
  • Radiotherapy and PCV chemotherapy
  • Amiens, France
  • +25 more
Jun 14, 2022

Proteomic Characterization of Aggressive Oligodendrogliomas

Recruiting
  • Oligodendroglioma
  • Proteomic analysis
  • Bron, France
  • +1 more
Apr 12, 2021

Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,

Completed
  • Adult Anaplastic Astrocytoma
  • +8 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 28, 2021

Oligodendroglioma Trial in Germany (CETEG, PCV, RT)

Recruiting
  • Oligodendroglioma
  • Heidelberg, Baden-Württemberg, Germany
  • +18 more
Sep 22, 2022

Anaplastic Oligodendroglioma, Oligoastrocytoma, Oligodendroglioma Trial in Los Angeles (Wear novoTTF-200A, Quality-of-Life

Withdrawn
  • Anaplastic Oligodendroglioma
  • +2 more
  • Wear novoTTF-200A
  • Quality-of-Life Assessment
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Dec 8, 2020

Clinical Development of Cancer-Specific MRS Biomarkers in

Completed
  • Malignant Gliomas
  • +2 more
  • 3 Tesla scanning
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 19, 2022

Educating Brain Tumor Patients Using Patient-specific

Recruiting
  • Brain Tumor
  • +7 more
  • Three-dimensional printed model
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Jul 10, 2021

Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Los Angeles, California
  • +11 more
Jul 1, 2022

MicroRNA-10b in Patients With Gliomas

Recruiting
  • Astrocytoma
  • +8 more
    • Boston, Massachusetts
    • +3 more
    May 30, 2021

    Clinical Development of MR Spectroscopy and Imaging in Brain

    Completed
    • Malignant Gliomas
    • +2 more
    • 3 Tesla Scanning
    • 7 Tesla Scanning
    • Dallas, Texas
      UT Southwestern Medical Center
    Jan 19, 2022

    Qualitative, Qualitative, and Functional Studies Over First Year

    Completed
    • Astrocytoma
    • +2 more
    • Hepatitis A Vaccine
    • +3 more
    • Winston-Salem, North Carolina
      Comprehensive Cancer Center of Wake Forest University
    Oct 28, 2021

    Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma Trial in Duarte (biological,

    Completed
    • Adult Anaplastic Astrocytoma
    • +6 more
    • E. coli CD-expressing genetically modified neural stem cells
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Sep 28, 2021

    Grade II Glioma, Grade III Glioma, Grade IV Glioma Trial in Boston (Microdevice)

    Recruiting
    • Grade II Glioma
    • +7 more
    • Microdevice
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Feb 22, 2021

    Oligodendroglioma; Oligoastrocytoma Trial in Marseille (Bis-Chloroethyl-Nitroso-Urea (BCNU) withTemozolomide)

    Completed
    • Oligodendroglioma; Oligoastrocytoma
    • Bis-Chloroethyl-Nitroso-Urea (BCNU) withTemozolomide
    • Marseille, France
      Assistance Publique - Hôpitaux de Marseille
    Feb 11, 2021

    Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,

    Terminated
    • Low Grade Glioma
    • +3 more
    • San Francisco, California
      University of California, San Francisco
    Nov 3, 2021

    Oligoastrocytoma, Astrocytoma, Oligodendroglioma Trial (device, procedure, other)

    Completed
    • Oligoastrocytoma
    • +2 more
    • fMRI
    • +2 more
    • (no location specified)
    Sep 1, 2020